Chaptered by Secretary of State. Chapter 1007, Statutes of 2026.
Summary
The bill lets pharmacists replace a prescribed biological medicine with a biosimilar or interchangeable product unless the doctor explicitly blocks it, and requires the pharmacist to record the substitution electronically. It also stops health plans and insurers from refusing coverage for a drug a patient is already taking, as long as the drug remains safe, effective and cost‑comparable. The aim is to lower drug costs and improve access for Californians.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SB 1094 changes status, plus AI-powered summaries and stage predictions.
Sign up free